Page 141 - 《中国药房》2026年7期
P. 141

severe chemotherapy associated neutropenia[J]. Sci Rep,  [20]  MIELNIK M,PODGAJNA-MIELNIK M,SZUDY-SZCZYREK
              2023,13(1):3371.                                    A,et  al.  Predicting  chemotherapy  toxicity  in  multiple
          [ 7 ]  GURUMURTHY  G,GURUMURTHY  J,GURUMURTHY           myeloma:the  prognostic  value  of  pre-treatment  serum
              S.  Machine  learning  in  paediatric  haematological  malig‐  cytokine  levels  of  interleukin-6,interleukin-8,monocyte
              nancies:a  systematic  review  of  prognosis,toxicity  and   chemoattractant  protein-1, and  vascular  endothelial
              treatment response models[J]. Pediatr Res,2025,97(2):  growth factor[J]. Front Immunol,2024,15:1377546.
              524-531.                                       [21]  AL TAWIL A,ALMAZAYDEH L,ALQUDAH B,et al.
          [ 8 ]  刘阳,李红健,吴建华,等. 乳腺癌化疗致骨髓抑制风险                       Predictive  modeling  for  breast  cancer  based  on  machine
              预测模型的系统评价[J]. 中国药房,2025,36(5):612-618.
                                                                  learning algorithms and features selection methods[J]. Int
          [ 9 ]  WHO  Classification  of  Tumours  Editorial  Board.  WHO   J Electr Comput Eng,2024,14(2):1937.
              classification of paediatric tumours[EB/OL].[2026-03-18].
                                                             [22]  XIAO J L,MO M,WANG Z Z,et al. The application and
              https://publications.iarc.who.int/Book-And-Report-Series/
                                                                  comparison of machine learning models for the prediction
              Who-Classification-Of-Tumours.
                                                                  of  breast  cancer  prognosis:retrospective  cohort  study[J].
          [10]  MOONS K G M,DE GROOT J A H,BOUWMEESTER
                                                                  JMIR Med Inform,2022,10(2):e33440.
              W,et al. Critical appraisal and data extraction for systematic
                                                             [23]  MONIRUJJAMAN  KHAN  M,ISLAM  S,SARKAR  S,
              reviews  of  prediction  modelling  studies:the  CHARMS
                                                                  et al. Machine learning based comparative analysis for breast
              checklist[J]. PLoS Med,2014,11(10):e1001744.
          [11]  陈香萍,张奕,庄一渝,等 . PROBAST:诊断或预后多因                    cancer prediction[J]. J Healthc Eng,2022,2022:4365855.
              素预测模型研究偏倚风险的评估工具[J]. 中国循证医学                    [24]  LOBATO-DELGADO B,PRIEGO-TORRES B,SANCHEZ-
              杂志,2020,20(6):737-744.                              MORILLO D. Combining molecular,imaging,and clini‐
          [12]  李祎涵. 基于自我报告的血液肿瘤患儿治疗相关发热性                         cal data analysis for predicting cancer prognosis[J]. Can‐
              中性粒细胞减少的预测模型研究[D]. 上海:上海交通大                         cers,2022,14(13):3215.
              学,2022.                                        [25]  BUICK J E,AUSTIN P C,CHESKES S,et al. Prediction
          [13]  徐蕊. 淋巴系恶性肿瘤患者大剂量甲氨蝶呤化疗后不良                         models in prehospital and emergency medicine research:
              反应预测模型的初步建立[D]. 乌鲁木齐:新疆医科大                          how to derive and internally validate a clinical prediction
              学,2018.                                             model[J]. Acad Emerg Med,2023,30(11):1150-1160.
          [14]  MIEDEMA K G E,DE BONT E S J M,OUDE NIJHUIS   [26]  TOUSIGNANT-LAFLAMME Y,HOULE  C,COOK  C,
              C S M,et al. Validation of a new risk assessment model   et  al.  Mastering  prognostic  tools:an  opportunity  to  en‐
              for  predicting  adverse  events  in  children  with  fever  and   hance personalized care and to optimize clinical outcomes
              chemotherapy-induced  neutropenia[J].  J  Clin  Oncol,  in physical therapy[J]. Phys Ther,2022,102(5):pzac023.
              2011,29(7):e182-e184.                          [27]  MISHRA A,MCCLELLAND R L,INOUE L Y T,et al.
          [15]  LYMAN  G  H,PONIEWIERSKI  M  S.  A  patient  risk
                                                                  Recalibration methods for improved clinical utility of risk
              model  of  chemotherapy-induced  febrile  neutropenia:les‐
                                                                  scores[J]. Med Decis Making,2022,42(4):500-512.
              sons learned from the ANC study group[J]. J Natl Compr
                                                             [28]  DHIMAN  P,MA  J,ANDAUR  NAVARRO  C  L,et  al.
              Canc Netw,2017,15(12):1543-1550.                    Risk  of  bias  of  prognostic  models  developed  using  ma‐
          [16]  WICKI S,KEISKER A,AEBI C,et al. Risk prediction of
                                                                  chine learning:a systematic review in oncology[J]. Diagn
              fever  in  neutropenia  in  children  with  cancer:a  step
                                                                  Progn Res,2022,6(1):13.
              towards individually tailored supportive therapy[J]. Pediatr
                                                             [29]  BRACHER-SMITH  M, CRAWFORD  K, ESCOTT-
              Blood Cancer,2008,51(6):778-783.
                                                                  PRICE V. Machine learning for genetic prediction of psy‐
          [17]  JIA H Y,LIANG L,CHEN X,et al. Predictive value of
              peri-chemotherapy  hematological  parameters  for  febrile   chiatric disorders:a systematic review[J]. Mol Psychiatry,
              neutropenia in patients with cancer[J]. Front Oncol,2024,  2021,26(1):70-79.
              14:1380195.                                    [30]  COLLINS G S,DHIMAN P,ANDAUR NAVARRO C L,
          [18]  VENÄLÄINEN M S,HEERVÄ E,HIRVONEN O,et al.         et  al.  Protocol  for  development  of  a  reporting  guideline
              Improved  risk  prediction  of  chemotherapy-induced   (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for
              neutropenia-model development and validation with real-  diagnostic and prognostic prediction model studies based
              world data[J]. Cancer Med,2022,11(3):654-663.       on  artificial  intelligence[J].  BMJ  Open,2021,11(7):
          [19]  CHEN  W  Q,PENG  L,ZENG  X  L,et  al.  Predictors  of    e048008.
              myelosuppression for patients with head and neck squamous     (收稿日期:2025-10-19  修回日期:2026-02-28)
              cell carcinoma after induction chemotherapy[J]. Clin Med                            (编辑:刘明伟)
              Insights Oncol,2024,18:11795549231219497.


          中国药房  2026年第37卷第7期                                                 China Pharmacy  2026 Vol. 37  No. 7    · 959 ·
   136   137   138   139   140   141   142   143   144   145   146